Most Active Stocks

COCHINSHIP
BSE
SCI
INDIGO
JUBLINGREA
GRSE
BEL
HAL
RELIANCE
MAZDOCK
CDSL
ONGC
RPOWER
OIL
BDL
HDFCBANK
SBIN
GESHIP
JUBLPHARMA
INFY

Shilpa Medicare Limited

Drug Manufacturers - Specialty & Generic | Healthcare

Company Overview

Shilpa Medicare Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, recombinant albumin in India, the United States, Europe, and internationally. The company offers various oncology and non-oncology APIs, such as anastrozole, acebrophylline, ambroxol hydrochloride, axitinib, azacitidine, abiraterone acetate, bendamustine HCL monohydrate, bicalutamide, bortezomib, busulphan, cabazitaxel amorphous, capecitabine, clofarabine, cyclophosphamide, dasatinib, decitabine, dimethyl fumarate, erlotinib HCL, enzalutamide, fingolimod hydrochloride, gemcitabine HCl, ibrutinib, imatinib mesylate, irinotecan HCl trihydrate, lenalidomide, lenvatinib mesylate, letrozole, and melphalan HCL. Its APIs also include nifedipine, oxaliplatin, pazopanib, pemetrexed disodium hemipentahydrate, pemetrexed dipotassium nonahydrate, pirfenidone, pomalidomide, sodium cholesteryl sulfate, sorafenib tosylate, sunitinib malate, temozolomide, teriflunomide, thalidomide, tranexamic and zoledronic acid, phenylephrine, citicholine, palbocicilib, nilotinib, nintedanib, praziquintol, carmustine, elthrombopag olamine, abacavir sulphate, tenofovir disproxyl fumarate API, tenofovir alfanamide, prucalopride succinate, and varenicline tartrate. In addition, the company provides intermediates; high-purity multi-cyclic and long-chain peptides; specialty and biopolymers; biologics; contract development and manufacturing services; and formulations, such as tablets, capsules, liquid injections, dry powder injectable products, orally disintegrating films, transdermal patches, and lyophilized injectables. Further, it is involved in the manufacture of specialized oncology formulations; and wind power generation activities. The company was formerly known as Shilpa Antibiotics Ltd and changed its name to Shilpa Medicare Limited in February 2003. Shilpa Medicare Limited was incorporated in 1987 and is based in Raichur, India.

Key Information

Market Cap

93673897984

Current Price

957.9

52 Week Range

519.5 - 980.0

Previous Close

953.7

Open

947.0

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Contact Details

Address

Shilpa House, #12-6-214/A-1 Hyderabad Road, Raichur, 584135, India

Phone

+91-85322-38704

Fax

+91-85322-38876

Website

https://www.vbshilpa.com

Financials

Day Low

939.25

Day High

962.3

Dividend Yield

PE Ratio

115.40964

Earnings Per Share

8.3

Beta

0.244

EBITDA

3170518016

Book Value

241.98

EPS

25.3

Company Officers

Name Title Age Year Born
Mr. Vishnukanth Chaturbhuj Bhutada B. Pharm MD & Director 62 1962
Mr. Alpesh Maheshkumar Dalal Chief Financial Officer 48 1976
Mr. Sharath Reddy Kalakota M.Pharma VP of Projects & Operations and Whole-Time Director 57 1967
Ms. Ritu Tiwary Company Secretary & Compliance Officer 47 1977
Dr. Jayant Karajgi Chief Operating Officer of Formulations 57 1967
Mr. Rajeev Saxena Senior Vice President – Domestic Formulations and Biologics 51 1973
Mr. Abhay Sapre Senior Vice President of Formulation 53 1971
Ms. Smita Holey Executive Vice President – Formulations for Small Molecules - -
Mr. Awez Mohinuddin Pathan Vice President 54 1970
Pramod Kumar Senior Vice President of Technical 61 1963

Company Details

Stock History

Explore More Stocks